Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 11, 2010, Pages 1096-1101

  Kimura, Kaoru ^a   Cheng, Xian Wu ^a,b,c   Nakamura, Kae ^a   Inoue, Aiko ^a   Hu, Lina ^a   Song, Haizhen ^a   Okumura, Kenji ^a   Iguchi, Akihisa ^d   Murohara, Toyoaki ^a   Kuzuya, Masafumi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YANBIAN UNIVERSITY   (China)

^c Kyung Hee University College of Medicine   (South Korea)

^d AICHI SHUKUTOKU UNIVERSITY   (Japan)

Author keywords

Matrix metalloproteinase 2; Smooth muscle cell; Tissue inhibitor of matrix metalloproteinase 2

Indexed keywords

GELATINASE A; MESSENGER RNA; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADHESION; ANIMAL CELL; AORTA; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REGULATION; GENE EXPRESSION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TARGETED GENE REPAIR; WESTERN BLOTTING;

ANEURYSM; ANIMALS; AORTA; ATHEROSCLEROSIS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 78049261004     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05441.x     Document Type: Article

References (37)

1. Kanda S, Kuzuya M, Ramos MA et al. Matrix metalloproteinase and alphavbeta 3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 998-1005.
2. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ. Res. 2002; 90: 251-62.
3. Cheng XW, Kuzuya M, Nakamura K et al. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 1864-70.
4. Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2006; 26: 1120-5.
5. Zhao L, Moos MP, Grabner R et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat. Med. 2004; 10: 966-73.
6. Yoshimura K, Aoki H, Ikeda Y et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med. 2005; 11: 1330-8.
7. Van Hinsbergh VW, Engelse MA, Quax PH. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2006; 26: 716-28.
8. Kuzuya M, Kanda S, Sasaki T et al. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation 2003; 108: 1375-81.
9. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 1994; 75: 539-45.
10. Zalba G, Fortuno A, Orbe J et al. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: Implications for human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007; 27: 587-93.
11. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 2002; 110: 625-32.
12. Nakamura K, Sasaki T, Cheng XW, Iguchi A, Sato K, Kuzuya M. Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation. Atherosclerosis 2009; 206: 355-61.
13. Cheng XW, Kuzuya M, Nakamura K et al. Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice. Circ. Res. 2007; 100: 904-13.
14. Cheng L, Mantile G, Pauly R et al. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation 1998; 98: 2195-201.
15. Ahmed SH, Clark LL, Pennington WR et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006; 113: 2089-96.
16. Lebrasseur NK, Duhaney TA, De Silva DS et al. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension. Hypertension 2007; 50: 489-96.
17. Cheng XW, Kuzuya M, Sasaki T et al. Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression. Cardiovasc. Res. 2004; 62: 594-602.
18. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization. Circulation 2001; 103: 926-33.
19. Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex. Kidney Int. 1993; 43: 163-70.
20. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J. Biol. Chem. 1996; 271: 17119-23.
21. Willenbrock F, Crabbe T, Slocombe PM et al. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase A. Biochemistry 1993; 32: 4330-7.
22. Cheng XW, Kuzuya M, Kanda S et al. Epigallocatechin-3-gallate binding to MMP-2 inhibits gelatinolytic activity without influencing the attachment to extracellular matrix proteins but enhances MMP-2 binding to TIMP-2. Arch. Biochem. Biophys. 2003; 415: 126-32.
23. Cheng XW, Murohara T, Kuzuya M et al. Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment. Am. J. Pathol. 2008; 173: 358-69.
24. Cheng XW, Kuzuya M, Nakamura K et al. Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3. Am. J. Pathol. 2006; 168: 685-94.
25. Shi GP, Sukhova GK, Kuzuya M et al. Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ. Res. 2003; 92: 493-500.
26. Guedez L, Stetler-Stevenson WG, Wolff L et al. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Invest. 1998; 102: 2002-10.
27. Li G, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res. 1999; 59: 6267-75.
28. Jiang Y, Wang M, Celiker MY et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res. 2001; 61: 2365-70.
29. Corcoran ML, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J. Biol. Chem. 1995; 270: 13453-9.
30. Yamashita K, Suzuki M, Iwata H et al. Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). FEBS Lett. 1996; 396: 103-7.
31. Taube ME, Liu XW, Fridman R, Kim HR. TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27 (KIP1) protein. Oncogene 2006; 25: 3041-8.
32. Wang T, Yamashita K, Iwata K, Hayakawa T. Both inhibitors of metalloproteinases-1 (TIMP-1) and TIMP-2 activate Ras but through tissue different pathways. Biochem. Biophys. Res. Commun. 2002; 296: 201-5.
33. Seo DW, Li H, Guedez L et al. TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism. Cell 2003; 114: 171-80.
34. Seo DW, Li H, Qu CK et al. Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J. Biol. Chem. 2006; 281: 3711-21.
35. Silletti S, Kessler T, Goldberg J, Boger DL, Cheresh DA. Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc. Natl Acad. Sci. USA 2001; 98: 119-24.
36. Brooks PC, Stromblad S, Sanders LC et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996; 85: 683-93.
37. Ohtake Y, Tojo H, Seiki M. Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle. J. Cell Sci. 2006; 119: 3822-32.